Clinical Infectious Diseases

Geographic Differences Among Tetanus Cases—United States, 2009–2023 ✅ Just Accepted 🔗 https://bit.ly/4zSY4h3

Interpreting Albumin-Carbapenem Effect Modification: Functional Form, Time Zero, and Local Overlap ✅ Just Accepted 🔗 https://bit.ly/3U3AbV0

Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort ✅ Just Accepted https://bit.ly/4z8Msqh

Association Between Neighbourhood-level Antibiotic Utilization and the Rate of Community-Associated C. difficile (CA-CDI) Infection: An Ecological Study ✅ Just Accepted 🔗 https://bit.ly/4yI1fqX

What Follows an Antibiotic Is Not Necessarily Caused by It ✅ Just Accepted 🔗 https://bit.ly/4exqmWb

Ertapenem in Hypoalbuminemia: Methodological and Pharmacokinetic Considerations ✅ Just Accepted 🔗 https://bit.ly/4zQVjNh

Hypoalbuminemia and Pharmacokinetics: Revisiting Fundamental Principles and Clinical Perspectives ✅ Just Accepted 🔗 https://bit.ly/47BCXUx

Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective ✅ Just Accepted https://bit.ly/4kcLjcx

Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions ✅ Just Accepted ⭐ Editor's Choice 🔗 https://bit.ly/4BcHhqZ

The Piperacillin-Tazobactam MIC Behaves Like a Prognostic Marker, Not a Pharmacodynamic Exposure ✅ Just Accepted 🔗 https://bit.ly/4zKnrSg

The piperacillin-tazobactam is behaving like a prognostic factor, but that does not negate the pharmacodynamic hypothesis ✅ Just Accepted 🔗 https://bit.ly/3VXonUL

HIV and Cancer Progression: Interpreting Real-World Evidence ✅ Just Accepted 🔗 https://bit.ly/47vVAZW

Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central Line–Associated Bloodstream Infection ✅ Just Accepted 🔗 https://bit.ly/4yUq7wp

Estimating Cancer Progression Risk by HIV Status: Design and Interpretation of Real-World Comparisons ✅ Just Accepted 🔗 https://bit.ly/4BceqTl

Drug plasmatic level determination in malaria late treatment failures supports CDC recommendation for extending the duration of artemether-lumefantrine treatment ✅ Just Accepted 🔗 https://bit.ly/4i5tZUe

Outpatient Antibiotic Fills and 30-Day Readmission Following Patient-Directed Discharge in Drug Use-Associated Infective Endocarditis in a National Medicaid Cohort ✅ Just Accepted https://bit.ly/4s7z8Qc

Leaving With Medical Advice: Why Prescribing Antibiotics to People with Endocarditis Who Leave the Hospital Early Makes Sense ✅ Just Accepted 🔗 https://bit.ly/4yoKZuY

Risk Factors and Therapeutic Consequences of Virologic Failure With Long-Acting Cabotegravir Plus Rilpivirine in the Dat’AIDS Cohort ✅ Just Accepted ⭐ Editor's Choice 🔗 https://bit.ly/4jWMUTJ

Does Low Baseline RPR Reflect Treatment Failure or Serologic Response Dynamics in Syphilis Among People With HIV? ✅ Just Accepted 🔗 https://bit.ly/4yKU8Pf

Low Baseline RPR Titers and Serological Response: Persistent Questions Among People with HIV ✅ Just Accepted 🔗 https://bit.ly/4zxAZAk

Waterborne outbreak of Mycobacterium abscessus in a UK specialist heart and lung hospital 2019-2026: patients, mitigations and implications 🔁 Repost 🔗 https://t.co/tJ7tNst1AH

Antimicrobials in a Box: A Primer on the Risks of Direct-to-Consumer Antimicrobial Preparedness Kits 🔁 Repost 🔗 https://bit.ly/4iRNtOi

Excess Hospital Use and Years of Life Lost After Cancer Diagnosis among People with HIV: A Nationwide Study in Spain ✅ Just Accepted 🔗 https://bit.ly/4s1YKOB

Antibiotic exposure and the emergence of multidrug resistant bacteria in patients with liver cirrhosis: A prospective cohort study ✅ Just Accepted 🔗 https://bit.ly/4j9YlqW

Shorter Antibiotic Duration for Pseudomonas Bacteremia: A Call for Future Trials ✅ Just Accepted https://bit.ly/4yKKBYL

Tipping the Scales: More Reasons to Re-evaluate Antibiotic Use in Patients with Advanced Liver Disease ✅ Just Accepted 🔗 https://bit.ly/4zw7j6V

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024–2025 🔁 Repost 🔗 https://t.co/EMSWOEkMy7

Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty ✅ Just Accepted 🔗 https://bit.ly/4yFEa90

Does the DOOR Account for Post-randomization Treatment Modification or Incorporate It? ✅ Just Accepted 🔗 https://bit.ly/4rSzhH4

Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis ✅ Just Accepted 🔗 https://bit.ly/4rVwCN3

Atypical Clostridioides difficile Infection: Defining a Mortality-Associated Dysmotility Phenotype 🔁 Repost 🔗 https://t.co/UMNbu7yBoU

On IDSA’s & HIVMA’s Science Speaks: Learn more about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk and other research in @jidjournal.bsky.social to inform clinical practice. https://bit.ly/4AYYFzi

The 2026 Guidance of the Infectious Diseases Society of America on the Treatment of Antimicrobial-Resistant Gram-Negative Infections and the Roadmap to European Implementation 🔁 Repost 🔗 https://t.co/w6aPYQ7daU

Enterococcal Bacteremia: A Day-4 Decision Requires Day-4 Eligibility 🔁 Repost 🔗 https://bit.ly/4xLSUlu

Interpreting Noninferiority in Risk-Stratified HIV Follow-up: Beyond a Single Margin ✅ Just Accepted 🔗 https://bit.ly/4y7YSxw

Interpreting Post Hoc Noninferiority Analyses in Reduced-Frequency HIV Follow Up ✅ Just Accepted 🔗 https://bit.ly/4rQIMH0

A Puzzle is More than One Piece: The Clean Margin in Diabetic Foot Osteomyelitis 🔁 Repost 🔗 https://t.co/TYzctUGpuZ

Relationship between Antibiotic Prescription and Survival in Hospice 🔁 Repost ⭐ Editor's Choice 🔗 https://t.co/seJhD5GDma

Time to Antibiotics or Time to Effective Antimicrobial Therapy? 🔁 Repost 🔗 https://t.co/uZdhB1ILN7

Initial Carbapenem Choice Versus Sustained Single-Group Therapy in the Albumin-Carbapenem Interaction 🔁 Repost 🔗 https://t.co/Zas0YSNOAs

Closing the Hepatitis B Vaccination Gap in Liver Transplant Candidates ✅ Just Accepted 🔗 https://bit.ly/4xYks7q

Waterborne outbreak of Mycobacterium abscessus in a UK specialist heart and lung hospital 2019-2026: patients, mitigations and implications ✅ Just Accepted 🔗 https://bit.ly/4jHjZCW

The 2026 Guidance of the Infectious Diseases Society of America on the Treatment of Antimicrobial-Resistant Gram-Negative Infections and the Roadmap to European Implementation ✅ Just Accepted 🔗 https://bit.ly/46WAdAQ

Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study ✅ Just Accepted 🔗 https://bit.ly/4jxC9qL

Antimicrobials in a Box: A Primer on the Risks of Direct-to-Consumer Antimicrobial Preparedness Kits ✅ Just Accepted 🔗 https://bit.ly/4iRNtOi

Turning Genomic Insights into Action: Interrupting Healthcare-Associated Mycobacterium abscessus Transmission Through Hospital Water Mitigation ✅ Just Accepted 🔗 https://bit.ly/3TE0BML

Marginal Bone in Diabetic Foot Osteomyelitis – an important part of a bigger puzzle 🔁 Repost 🔗 https://t.co/Z7Wrk4stph

Safety of tuberculosis preventive treatment among people receiving or about to initiate immunosuppressive medications: a systematic review and meta-analysis 🔁 Repost 🔗 https://bit.ly/4xCB6Jq

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024–2025 ✅ Just Accepted 🔗 https://bit.ly/47oa0Lz

🚨ICYMI: New in CID! A new article series explores recent advances in point-of-care testing that address the need for more rapid, accessible and accurate infectious diseases diagnostics. Read more: https://bit.ly/41hmOjx